Two asset management stocks to back in 2014

ON EQUITIES

clock

Shares in asset managers were among the most reliable financials during 2013, giving decent growth alongside well-covered dividends. Guinness manager Will Riley picks two asset managers set for more share price appreciation.

2013 was a good year for asset managers, with rising equity markets bringing cheer for both the businesses and their stocks. The MSCI World Index returned 21.2% to the end of December 2013, prompting significant investment inflows. Aberdeen’s acquisition of SWIP triggered an instant 14.7% jump in its share price and earned the sector mainstream media attention. Over the long term, we expect asset managers to grow their earnings and free cashflow faster than the broad market. While last year was a good year for the sector, we remain optimistic about its prospects. One company that i...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot